Searched for
PATENT SETTLEMENT
Moderna stocks: MRNA shares jump in US Stock market today after pharma giant surpasses Wall Street estimatesModerna had earlier posted a loss of $2.52 per share a year earlier, while analysts expected a loss of $3.96 per share.01 May, 2026, 04.15 PM IST- Non-violation complaints under WTO's TRIPS agreement: An explainerWorld Trade Organisation members could not agree to extend a safeguard on intellectual property rules. This means the moratorium on non-vio...30 Mar, 2026, 09.23 PM IST
- Biocon Biologics settles patent issue; paves way for launch of biosimilar product in CanadaBiocon Biologics has settled patent disputes with Bayer Inc and Regeneron Pharmaceuticals Inc, enabling the launch of Yesafili, an ophthalm...04 Mar, 2024, 11.47 AM IST
- Apple loses second bid to challenge Qualcomm patents at US Supreme CourtQualcomm sued Apple in San Diego federal court in 2017, arguing that its iPhones, iPads and Apple Watches infringed a variety of mobile-tec...03 Oct, 2022, 08.58 PM IST
- Teva settles patent dispute with Orchid PharmaTeva has settled patent dispute with Orchid Chemicals & Pharma pertaining to Parkinson’s disease drug Azilect (rasagiline mesylate) in the ...01 May, 2013, 10.45 PM IST
- Apple, Motorola discussed patent settlement: EUApple held talks with Motorola at the end of last year on a potential cross-licensing settlement to end a dispute over smartphone patents, ...14 Mar, 2012, 12.40 AM IST
- Dr Reddy's reach settlement with Wyeth over EffexorDr Reddy's Laboratories has reached a deal with Wyeth LLC over a patent litigation involving generic version of blockbuster anti-depressant...22 Apr, 2011, 09.18 PM IST
- Drug cos patent settlements to cost Americans $3.5 bn annuallyCash settlements of patent disputes between innovator companies and generic medicine makers are delaying entry of affordable drugs in US ma...14 Jan, 2010, 10.00 PM IST
- First to file Para IV suits on steady rise, along with patent settlementsA latest study conducted in US by Stanford Group Company, a member of the Stanford Financial Group shows that patent challenges as well as ...17 Mar, 2009, 12.12 PM IST
- Pharma games cost EU €3 b annuallyGlobal drug companies delayed or blocked entry of competing low-cost medicines by an average of seven months, costing EU citizens €3 bn eve...01 Dec, 2008, 12.01 AM IST
- Pharma games cost EU €3 b annuallyGlobal drug companies delayed or blocked entry of competing low-cost medicines by an average of seven months, costing EU citizens €3 bn eve...30 Nov, 2008, 11.01 PM IST
- Big pharma games cost EU citizens € 3bnGlobal drug companies delayed or blocked entry of competing low-cost medicines by an average of seven months, costing EU citizens € 3 billi...29 Nov, 2008, 09.39 AM IST
- Indian generic companies may tread Ranbaxy pathRanbaxy's patent settlement with Pfizer may lead more Indian generic cos to go for out-of-court settlements with their innovator counterpar...19 Jun, 2008, 01.00 AM IST
- Ranbaxy strikes deal on Nexium with AstraZenecaRanbaxy has entered into a series of out-of-court settlements with AstraZeneca with estimates of a revenue upside of $1.25-1.5 billion. Go ...16 Apr, 2008, 02.00 AM IST
- Ranbaxy settles generic sale dispute with GSKRanbaxy Laboratories has reached an out-of-court settlement with UK’s pharma major GlaxoSmithKline to market generic copies of the latter’s...22 Jan, 2008, 12.00 AM IST
- Generic firms & innovators tie up to cut legal costsIn these settlements, the generic company typically agrees to delay its entrance in the market in exchange for certain benefits. Lifestyle ...17 Nov, 2007, 01.25 PM IST
- Pharma patent disputes out-of-courtUnder such settlements, cos agree to delay entrance in market for certain benefits, such as licences to other patents.02 Aug, 2007, 12.00 AM IST
Load More
